Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation

Peroxisome proliferator-activated receptorδ (PPARδ) regulates a multiplicity of physiological processes associated with glucose and lipid metabolism, inflammation, and proliferation. One or more of these processes likely create risk factors associated with the ability of PPARδ agonists to promote t...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Claire B. Pollock, Olga Rodriguez, Philip L. Martin, Chris Albanese, Xin Li, Levy Kopelovich, Robert I. Glazer
פורמט: Article
שפה:English
יצא לאור: Hindawi Limited 2010-01-01
סדרה:PPAR Research
גישה מקוונת:http://dx.doi.org/10.1155/2010/571783
_version_ 1827089724494315520
author Claire B. Pollock
Olga Rodriguez
Philip L. Martin
Chris Albanese
Xin Li
Levy Kopelovich
Robert I. Glazer
author_facet Claire B. Pollock
Olga Rodriguez
Philip L. Martin
Chris Albanese
Xin Li
Levy Kopelovich
Robert I. Glazer
author_sort Claire B. Pollock
collection DOAJ
description Peroxisome proliferator-activated receptorδ (PPARδ) regulates a multiplicity of physiological processes associated with glucose and lipid metabolism, inflammation, and proliferation. One or more of these processes likely create risk factors associated with the ability of PPARδ agonists to promote tumorigenesis in some organs. In the present study, we describe a new gastric tumor mouse model that is dependent on the potent and highly selective PPARδ agonist GW501516 following carcinogen administration. The progression of gastric tumorigenesis was rapid as determined by magnetic resonance imaging and resulted in highly metastatic squamous cell carcinomas of the forestomach within two months. Tumorigenesis was associated with gene expression signatures indicative of cell adhesion, invasion, inflammation, and metabolism. Increased PPARδ expression in tumors correlated with increased PDK1, Akt, β-catenin, and S100A9 expression. The rapid development of metastatic gastric tumors in this model will be useful for evaluating preventive and therapeutic interventions in this disease.
first_indexed 2025-03-20T05:29:04Z
format Article
id doaj.art-88b51a38a8d74c59855dc92b40531fb3
institution Directory Open Access Journal
issn 1687-4757
1687-4765
language English
last_indexed 2025-03-20T05:29:04Z
publishDate 2010-01-01
publisher Hindawi Limited
record_format Article
series PPAR Research
spelling doaj.art-88b51a38a8d74c59855dc92b40531fb32024-10-03T05:24:00ZengHindawi LimitedPPAR Research1687-47571687-47652010-01-01201010.1155/2010/571783571783Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ ActivationClaire B. Pollock0Olga Rodriguez1Philip L. Martin2Chris Albanese3Xin Li4Levy Kopelovich5Robert I. Glazer6Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20057, USADepartment of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20057, USACenter for Advanced Preclinical Research, SAIC/NCI-Frederick, Frederick, MD 21702, USADepartment of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20057, USADepartment of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Washington, DC 20057, USAChemoprevention Agent Development and Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20814, USADepartment of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20057, USAPeroxisome proliferator-activated receptorδ (PPARδ) regulates a multiplicity of physiological processes associated with glucose and lipid metabolism, inflammation, and proliferation. One or more of these processes likely create risk factors associated with the ability of PPARδ agonists to promote tumorigenesis in some organs. In the present study, we describe a new gastric tumor mouse model that is dependent on the potent and highly selective PPARδ agonist GW501516 following carcinogen administration. The progression of gastric tumorigenesis was rapid as determined by magnetic resonance imaging and resulted in highly metastatic squamous cell carcinomas of the forestomach within two months. Tumorigenesis was associated with gene expression signatures indicative of cell adhesion, invasion, inflammation, and metabolism. Increased PPARδ expression in tumors correlated with increased PDK1, Akt, β-catenin, and S100A9 expression. The rapid development of metastatic gastric tumors in this model will be useful for evaluating preventive and therapeutic interventions in this disease.http://dx.doi.org/10.1155/2010/571783
spellingShingle Claire B. Pollock
Olga Rodriguez
Philip L. Martin
Chris Albanese
Xin Li
Levy Kopelovich
Robert I. Glazer
Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
PPAR Research
title Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
title_full Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
title_fullStr Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
title_full_unstemmed Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
title_short Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
title_sort induction of metastatic gastric cancer by peroxisome proliferator activated receptorδ activation
url http://dx.doi.org/10.1155/2010/571783
work_keys_str_mv AT clairebpollock inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation
AT olgarodriguez inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation
AT philiplmartin inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation
AT chrisalbanese inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation
AT xinli inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation
AT levykopelovich inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation
AT robertiglazer inductionofmetastaticgastriccancerbyperoxisomeproliferatoractivatedreceptordactivation